Status:
COMPLETED
Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder
Lead Sponsor:
Eli Lilly and Company
Conditions:
Schizophrenic Disorders
Schizoaffective Disorder
Eligibility:
All Genders
18-76 years
Phase:
PHASE3
Brief Summary
This is a long-term, open-label clinical study designed to enable longer-term treatment of patients completing other clinical studies with intramuscular olanzapine depot. Key objectives of the study ...
Eligibility Criteria
Inclusion
- Patients must have schizophrenia
- Female patients of childbearing potential must be using a medically accepted means of contraception
- Patients must have completed (within 10 days) another IM olanzapine depot study if permitted by that study's protocol.
Exclusion
- Patients must not have participated in a clinical trial of another investigational drug, including olanzapine, within 1 month (30 days) prior to study entry
- Female patients must not be pregnant or breast-feeding
- Patients must not be experiencing acute, serious or unstable medical conditions other than schizophrenia or schizoaffective disorder
- Patients must not have a substance (except nicotine or caffeine) dependence within the past 30 days
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
931 Patients enrolled
Trial Details
Trial ID
NCT00088465
Start Date
August 1 2004
End Date
December 1 2010
Last Update
January 11 2012
Active Locations (92)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Orange, California, United States, 92868
2
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Pasadena, California, United States, 91107
3
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
San Diego, California, United States, 92123
4
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Santa Ana, California, United States, 92705